Okapi Sciences logo — Enhancing leadership in pet therapeutics with high value ant...

Okapi Sciences

Enhancing leadership in pet therapeutics with high value antiviral drugs and strong academic partnerships for advancing feline health.

Founded 2007 Grant Total: $8.50M Biotechnology, Health and Wellness

General Information

Company Name Okapi Sciences
Founded Year 2007
Industries Biotechnology, Health and Wellness
Funding Stage Grant
Social

Get notified when Okapi Sciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Okapi Sciences

Okapi Sciences is a Belgium-based biotechnology company focused on enhancing leadership in pet therapeutics. The company has developed a proprietary antiviral platform and is currently advancing five clinical-stage candidates targeting significant viral diseases in pets. The strategic acquisition of Okapi by Aratana has strengthened the latter's position in the pet therapeutics market by combining a talented team, strong academic collaborations, innovative technologies, and products. The recent grant investment received on 02 July 2013 from The Institute for the Promotion of Innovation by Science and Technology in Flanders validates the market potential of Okapi's high-value antiviral drugs. With a specific focus on treating feline herpes and feline immunodeficiency virus, Okapi Sciences is poised to make significant contributions to advancing feline health within the health and wellness industry.

Taxonomy: pet therapeutics, antiviral drugs, animal health, veterinary medicine, biopharmaceuticals, Belgium-based company, clinical-stage candidates, feline health, academic partnerships, strategic acquisition, innovative technologies, geographic location, feline herpes, feline immunodeficiency virus, pipeline development

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 02 Jul 2013
Series A •••••• 5
Investor Investor
•••• ••••
03 Nov 2008
Venture Round •••••• 1
Investor
18 Sep 2007

Okapi Sciences Alternatives & Competitors

Okapi Sciences vs

SAVING LIVES by applying recent advancement in genomics and proteomics on infectious diseases that h...

6 employees
Biotechnology, Life Sciences
Okapi Sciences vs

The most palatable alternative protein on Earth

Seed
6 employees
Okapi Sciences vs
Gallant
Gallant United States

Restoring Health. Redefining Veterinary Care. Off-the-shelf stem cell therapies that target the root...

Seed
67 employees
Biotechnology, Health and Wellness

FAQ About Okapi Sciences

Enhancing leadership in pet therapeutics with high value antiviral drugs and strong academic partnerships for advancing feline health.
Okapi Sciences was founded in 2007.
Okapi Sciences operates in the following industries: Biotechnology, Health and Wellness.
Okapi Sciences has completed 3 funding rounds, raising a total of $8.50M. The latest funding stage is Grant.
Top alternatives and competitors to Okapi Sciences include Biovalence Technologies Pte Ltd, Proteine Resources, Gallant, Akston Biosciences Corporation, Lenda Company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Okapi Sciences and Biovalence Technologies Pte Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Okapi Sciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy